ConductScience.org, home

Paper4132697

Microbiological assay of bleomycin: inactivation, tissue distribution, and clearance.

Onuma T and 4 others. Cancer, 1974. Cited by 121 papers, by iCite.

Cite this record

ConductScience Library. Microbiological assay of bleomycin: inactivation, tissue distribution, and clearance. Papers, record 4132697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4132697

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Microbiological assay of bleomycin: inactivation, tissue distribution, and clearance.
PubMed
Journal
Cancer
PubMed
Year
1974
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
121
iCite
Relative citation ratio, by iCite
4.97
iCite
Revised in PubMed
2019-06-19
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Onuma TT
2Holland JFJ F
3Masuda HH
4Waligunda JAJ A
5Goldberg GAG A

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BleomycinMajor topic
Animals
Bacillus subtilis
Biological Assay
Carcinoma, Ehrlich Tumor
Humans
Intestinal Mucosa
Kidney
Kinetics
Liver
Lung
Mice
Muscles
Skin
Time Factors

Source PubMed

Download CSV of topics

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 121 citations.

PMIDTitleJournalYearIn PapersSource
39682260A High-Throughput Immune-Oncology Screen Identifies Immunostimulatory Properties of Cytotoxic Chemotherapy Agents in TNBC.Cancers (Basel)2024https://conductscience.org/library/papers/39682260PubMed
37169644Chemotherapeutical treatment of basal cell carcinoma with bleomycin via microinfusion of the drug into the skin (MMP®).An Bras Dermatol2023https://conductscience.org/library/papers/37169644PubMed
35799941Target-induced activation of DNAzyme for highly sensitive colorimetric detection of bleomycin via DNA scission.RSC Adv2022https://conductscience.org/library/papers/35799941PubMed
34977500Nuclear respiratory factor-1 negatively regulates TGF-β1 and attenuates pulmonary fibrosis.iScience2022https://conductscience.org/library/papers/34977500PubMed
31289762Oxidative Toxicology of Bleomycin: Role of the Extracellular Redox Environment.Curr Opin Toxicol2019https://conductscience.org/library/papers/31289762PubMed
19129758Pulmonary fibrosis: pathogenesis, etiology and regulation.Mucosal Immunol2009https://conductscience.org/library/papers/19129758PubMed
15632004IL-9 protects against bleomycin-induced lung injury: involvement of prostaglandins.Am J Pathol2005https://conductscience.org/library/papers/15632004PubMed
11007108Electrochemotherapy for colorectal cancer with commonly used chemotherapeutic agents in a mouse model.Dig Dis Sci2000https://conductscience.org/library/papers/11007108PubMed
7529523Decrease in pulmonary function during bleomycin-containing combination chemotherapy for testicular cancer: not only a bleomycin effect.Br J Cancer1995https://conductscience.org/library/papers/7529523PubMed
6375139Intestinal and liver toxicity of antineoplastic drugs.West J Med1984https://conductscience.org/library/papers/6375139PubMed
6203733Drug-induced pulmonary fibrosis.Environ Health Perspect1984https://conductscience.org/library/papers/6203733PubMed
6190169Lack of metabolism as the biochemical basis of bleomycin-induced pulmonary toxicity.Proc Natl Acad Sci U S A1983https://conductscience.org/library/papers/6190169PubMed
6183016Bleomycin clinical pharmacology by radioimmunoassay.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/6183016PubMed
3555940Pharmacokinetics of anticancer drugs in children.Clin Pharmacokinet1987https://conductscience.org/library/papers/3555940PubMed
2191847Antineoplastic drugs in 1990. A review (Part II).Drugs1990https://conductscience.org/library/papers/2191847PubMed
1711838Mechanisms of bleomycin-induced lung damage.Arch Toxicol1991https://conductscience.org/library/papers/1711838PubMed
1107513Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.J Pharmacokinet Biopharm1975https://conductscience.org/library/papers/1107513PubMed
86392Bleomycin pharmacokinetics in man. I. Intravenous administration.Cancer Chemother Pharmacol1978https://conductscience.org/library/papers/86392PubMed
68783Radioimmunoassay of bleomycin in plasma and urine.Br J Cancer1977https://conductscience.org/library/papers/68783PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4132697

GET https://conductscience.org/api/papers/v1/4132697/authors